India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns about misuse for cosmetic reasons are growing. Regulators are intervening in advertising. The drugs also have side effects and can lead to weight regain. This boom is impacting pharmaceutical research priorities.